Company intelligence / Profile preview
Shanxi Zhendong Pharmaceutical Co., Ltd.
Changzhi City, Shanxi Province, Chinazdjt.com ↗
- Ownership
- Private
- Employees
- ~6000
- Development stage
- Commercial
01
Overview
The company has multiple approved drugs in China including Amoxicillin/Flucloxacillin Magnesium and various traditional Chinese medicines. They also have products in clinical development including FuFangKuShen (Phase 3) for Rectal Cancer, Changrui Enema Powder (Phase 2) for Radiation proctitis, and Larotaxel Dihydrate (Phase 1) for Advanced Malignant Solid Neoplasm[9].
- Therapeutic areas
- Men's HealthOncologyPulmonologyHematologyDermatologyGastroenterologyCardiovascularNephrologyInfectious Diseases
- Modalities
- Small molecule drugsHerbal medicineTraditional Chinese Medicine
- Industry
- Biotech
02
Drug pipeline
14 assets13 more assets in the full pipeline.
Beyond the preview
Go deeper on Shanxi Zhendong Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanxi Zhendong Pharmaceutical Co., Ltd..